Transgene SA focuses on developing immunotherapies for cancer treatment by harnessing the power of viruses to augment the body’s immune response against tumors.
1979
France
51 - 200 employees
Biotechnology
$1M - 10M in revenue
Not profitable
Industry rank: 14 out of 251
Total electricity consumption
and % renewables
(MWh, % of consumption)
Industry rank: 14 out of 251
Total electricity
Share of renewable electricity
Industry benchmark
CO2e per visit (g)
Industry benchmark
Total Annual
Revenue & EBITDA
($ B)
Margin as % of revenue
R&D as % of revenue
Analyst consensus vs actuals
($ B)
0.0
▼ 13.3%
0.0
▼ 56.3%
0.0
▼ 32.3%
0.0
2030Not available
Available
Not available
Available
5 out of 18 incl. management
Not available
Not available
Available
Not available
Not available
Not available
Not available